Benazepril Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

21 API Suppliers, 17 USDMF, 9 CEP/COS, 2 JDMF, 6 EU WC, 12 NDC API, 8 Listed Suppliers, $ API Reference Price

INTERMEDIATES

2 Intermediates Suppliers

2 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

163 FDF Dossiers, 150 FDA Orange Book, 6 Canada, 7 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 40MG, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 10MG BASE;20MG, CAPSULE;ORAL - EQ 10MG BASE;40MG, CAPSULE;ORAL - EQ 2.5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;10MG, CAPSULE;ORAL - EQ 5MG BASE;20MG, CAPSULE;ORAL - EQ 5MG BASE;40MG

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 9 DKSH, 1 Jai Radhe Sales, 5 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 12 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 36 BASF, 2 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 13 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 38 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 20 Roquette, 16 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

84 Fillers, Diluents & Binders, 56 Coating Systems & Additives, 43 Direct Compression, 34 Solubilizers, 34 Controlled & Modified Release, 33 Disintegrants & Superdisintegrants, 33 Thickeners and Stabilizers, 29 Granulation, 27 Lubricants & Glidants, 23 Topical, 20 Film Formers & Plasticizers, 19 Parenteral, 19 Co-Processed Excipients, 14 Emulsifying Agents, 9 Taste Masking, 9 Chewable & Orodispersible Aids, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 7 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 4 Rheology Modifiers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 4 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 20 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 1 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19851 / DOSAGE - TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BENAZEPRIL HYDROCHLORIDE(UNII: N1SN99T69T) (BENAZEPRILAT - UNII:JRM708L703)	BENAZEPRIL HYDROCHLORIDE	20mg

Inactive Ingredients

Ingredient Name	PD-Rx Pharmaceuticals, Inc.
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE(68401960MK)
HYDROGENATED CASTOR OIL(ZF94AP8MEY)
HYPROMELLOSES(3NXW29V3WO)
LACTOSE(J2B2A4N98G)
POLYSORBATE 80(6OZP39ZG8H)
SILICON DIOXIDE(ETJ7Z6XBU4)
STARCH, POTATO(8I089SAH3T)
TALC(7SEV7J4R1U)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Benazepril Hydrochloride